Back

Impact of routine angiographic follow-up on long-term clinical outcomes in patients with multivessel disease underwent successful percutaneous coronary intervention

30 August 2026 (13:15 - 13:45)
Organised by: Logo
Congress Presentation Part of: Drug-coated balloon or drug-eluting stent: tailoring de novo interventions Percutaneous Coronary Intervention (PCI) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms You Jin Lee

Seoul (Korea (Republic of))

3 More presentations in this session

Presentation thumbnail
Temporal trends and clinical characteristics of drug-coated balloon angioplasty for de dovo coronary lesions: A five-year analysis from the ORPKI Registry
Professor T. Rakowski (Krakow, PL)
Abstract
Presentation thumbnail
Safety and effectiveness of drug-coated balloon angioplasty in de novo coronary lesions: 6-month outcomes from a multicenter registry
Doctor I. Kachrimanidis (Athens, GR)
Abstract
Presentation thumbnail
Impact of stepwise dual antiplatelet therapy de-escalation in patients with proximal LAD disease undergoing drug-coated balloon angioplasty: insights from the REC-CAGEFREE II trial
Professor C. Gao (Hefei, CN)
Abstract

Access the full session

Session thumbnail
Drug-coated balloon or drug-eluting stent: tailoring de novo interventions

The Event

Event poster

ESC Congress 2026

30 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Long-term follow-up after percutaneous coronary interventions for chronic total occlusions.
1 September 2025
thumbnail
Congress Presentation
A UK retrospective analysis of recurrent cardiovascular events following acute myocardial infarction in patients with multivessel disease and additional risk factors
28 August 2022
thumbnail
Congress Presentation
Comparing intravascular and angiographic imaging strategies for PCI guidance in acute coronary syndromes: a review of reviews
20 March 2026
thumbnail
Congress Presentation
Effect of coronary disease characteristics on prognostic relevance of residual ischemia after stent implantation
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources